Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2015; 21(22): 6842-6849
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6842
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6842
Endoscopic treatment of gastroparesis
Thomas R McCarty, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8019, United States
Tarun Rustagi, Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8019, United States
Author contributions: McCarty TR and Rustagi T equally contributed to this paper.
Conflict-of-interest: Authors have nothing to disclose.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Tarun Rustagi, MD, Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT 06520-8019, United States. tarunrustagi06@gmail.com
Telephone: +1-860-2214034 Fax: +1-203-7371755
Received: January 20, 2015
Peer-review started: January 20, 2015
First decision: February 10, 2015
Revised: March 5, 2015
Accepted: April 28, 2015
Article in press: April 28, 2015
Published online: June 14, 2015
Peer-review started: January 20, 2015
First decision: February 10, 2015
Revised: March 5, 2015
Accepted: April 28, 2015
Article in press: April 28, 2015
Published online: June 14, 2015
Core Tip
Core tip: Although a majority of gastroparesis patients respond to medical treatment, patients with refractory symptoms pose a therapeutic challenge and are often referred for surgical management. Endoscopic management of gastroparesis seeks to treat delayed gastric emptying with a less invasive approach compared to the surgical approach. Endoscopic treatment of gastroparesis most commonly involves intrapyloric botulinum toxin injection; however, there exists a variety of endoscopic approaches on the horizon that have the potential to radically shift the standard of care for refractory patients.